176 related articles for article (PubMed ID: 29232380)
21. A pathogenic role for ER stress-induced autophagy and ER chaperone GRP78/BiP in T lymphocyte systemic lupus erythematosus.
Lee WS; Sung MS; Lee EG; Yoo HG; Cheon YH; Chae HJ; Yoo WH
J Leukoc Biol; 2015 Feb; 97(2):425-33. PubMed ID: 25516752
[TBL] [Abstract][Full Text] [Related]
22. Modulation of radiation response after epidermal growth factor receptor blockade in squamous cell carcinomas: inhibition of damage repair, cell cycle kinetics, and tumor angiogenesis.
Huang SM; Harari PM
Clin Cancer Res; 2000 Jun; 6(6):2166-74. PubMed ID: 10873065
[TBL] [Abstract][Full Text] [Related]
23. Heat shock protein 90 (HSP90) is overexpressed in p16-negative oropharyngeal squamous cell carcinoma, and its inhibition in vitro potentiates the effects of chemoradiation.
Patel K; Wen J; Magliocca K; Muller S; Liu Y; Chen ZG; Saba N; Diaz R
Cancer Chemother Pharmacol; 2014 Nov; 74(5):1015-22. PubMed ID: 25205430
[TBL] [Abstract][Full Text] [Related]
24. Different Roles of GRP78 on Cell Proliferation and Apoptosis in Cartilage Development.
Xiong Z; Jiang R; Li X; Liu Y; Guo F
Int J Mol Sci; 2015 Sep; 16(9):21153-76. PubMed ID: 26370957
[TBL] [Abstract][Full Text] [Related]
25. The effects of cetuximab alone and in combination with radiation and/or chemotherapy in lung cancer.
Raben D; Helfrich B; Chan DC; Ciardiello F; Zhao L; Franklin W; Barón AE; Zeng C; Johnson TK; Bunn PA
Clin Cancer Res; 2005 Jan; 11(2 Pt 1):795-805. PubMed ID: 15701870
[TBL] [Abstract][Full Text] [Related]
26. Combined epidermal growth factor receptor targeting with the tyrosine kinase inhibitor gefitinib (ZD1839) and the monoclonal antibody cetuximab (IMC-C225): superiority over single-agent receptor targeting.
Matar P; Rojo F; Cassia R; Moreno-Bueno G; Di Cosimo S; Tabernero J; Guzmán M; Rodriguez S; Arribas J; Palacios J; Baselga J
Clin Cancer Res; 2004 Oct; 10(19):6487-501. PubMed ID: 15475436
[TBL] [Abstract][Full Text] [Related]
27. Geranylgeranylacetone, an inducer of the 70-kDa heat shock protein (HSP70), elicits unfolded protein response and coordinates cellular fate independently of HSP70.
Endo S; Hiramatsu N; Hayakawa K; Okamura M; Kasai A; Tagawa Y; Sawada N; Yao J; Kitamura M
Mol Pharmacol; 2007 Nov; 72(5):1337-48. PubMed ID: 17702888
[TBL] [Abstract][Full Text] [Related]
28. Enhanced Susceptibility to 5-Fluorouracil in Human Colon Cancer Cells by Silencing of GRP78.
Yun S; Han YS; Lee JH; Kim S; Lee SH
Anticancer Res; 2017 Jun; 37(6):2975-2984. PubMed ID: 28551635
[TBL] [Abstract][Full Text] [Related]
29. Pharmacological inhibition of EGFR tyrosine kinase affects ILK-mediated cellular radiosensitization in vitro.
Eke I; Sandfort V; Storch K; Baumann M; Röper B; Cordes N
Int J Radiat Biol; 2007; 83(11-12):793-802. PubMed ID: 18058367
[TBL] [Abstract][Full Text] [Related]
30. Growth and molecular interactions of the anti-EGFR antibody cetuximab and the DNA cross-linking agent cisplatin in gefitinib-resistant MDA-MB-468 cells: new prospects in the treatment of triple-negative/basal-like breast cancer.
Oliveras-Ferraros C; Vazquez-Martin A; López-Bonet E; Martín-Castillo B; Del Barco S; Brunet J; Menendez JA
Int J Oncol; 2008 Dec; 33(6):1165-76. PubMed ID: 19020749
[TBL] [Abstract][Full Text] [Related]
31. The molecular mechanisms of XBP-1 gene silencing on IRE1α-TRAF2-ASK1-JNK pathways in oral squamous cell carcinoma under endoplasmic reticulum stress.
Chen H; Yang H; Pan L; Wang W; Liu X; Ren X; Liu Y; Liu W; Zhang Y; Jiang L; Li K; Zhang B; Wang LX
Biomed Pharmacother; 2016 Feb; 77():108-13. PubMed ID: 26796273
[TBL] [Abstract][Full Text] [Related]
32. Cooperative effect of BI-69A11 and celecoxib enhances radiosensitization by modulating DNA damage repair in colon carcinoma.
Pal I; Dey KK; Chaurasia M; Parida S; Das S; Rajesh Y; Sharma K; Chowdhury T; Mandal M
Tumour Biol; 2016 May; 37(5):6389-402. PubMed ID: 26631035
[TBL] [Abstract][Full Text] [Related]
33. Enhancement of radiosensitivity in head and neck cancer cells by ZD1839 ('IRESSA'), a selective epidermal growth factor receptor tyrosine kinase inhibitor.
Shintani S; Kiyota A; Mihara M; Sumida T; Kayahara H; Nakashiro K; Hamakawa H
Am J Clin Oncol; 2003 Oct; 26(5):e150-6. PubMed ID: 14528090
[TBL] [Abstract][Full Text] [Related]
34. ATF6 upregulates XBP1S and inhibits ER stress-mediated apoptosis in osteoarthritis cartilage.
Guo FJ; Xiong Z; Lu X; Ye M; Han X; Jiang R
Cell Signal; 2014 Feb; 26(2):332-42. PubMed ID: 24269637
[TBL] [Abstract][Full Text] [Related]
35. Prodigiosin activates endoplasmic reticulum stress cell death pathway in human breast carcinoma cell lines.
Pan MY; Shen YC; Lu CH; Yang SY; Ho TF; Peng YT; Chang CC
Toxicol Appl Pharmacol; 2012 Dec; 265(3):325-34. PubMed ID: 22982536
[TBL] [Abstract][Full Text] [Related]
36. Endoplasmic reticulum stress is activated in endometrial adenocarcinoma.
Bifulco G; Miele C; Di Jeso B; Beguinot F; Nappi C; Di Carlo C; Capuozzo S; Terrazzano G; Insabato L; Ulianich L
Gynecol Oncol; 2012 Apr; 125(1):220-5. PubMed ID: 22146569
[TBL] [Abstract][Full Text] [Related]
37. Induction of MET by ionizing radiation and its role in radioresistance and invasive growth of cancer.
De Bacco F; Luraghi P; Medico E; Reato G; Girolami F; Perera T; Gabriele P; Comoglio PM; Boccaccio C
J Natl Cancer Inst; 2011 Apr; 103(8):645-61. PubMed ID: 21464397
[TBL] [Abstract][Full Text] [Related]
38. Cetuximab: an epidermal growth factor receptor chemeric human-murine monoclonal antibody.
Harding J; Burtness B
Drugs Today (Barc); 2005 Feb; 41(2):107-27. PubMed ID: 15821783
[TBL] [Abstract][Full Text] [Related]
39. Cetuximab-resistant oral squamous cell carcinoma cells become sensitive in anchorage-independent culture conditions through the activation of the EGFR/AKT pathway.
Ohnishi Y; Yasui H; Kakudo K; Nozaki M
Int J Oncol; 2015 Dec; 47(6):2165-72. PubMed ID: 26497980
[TBL] [Abstract][Full Text] [Related]
40. Treatment effect of buparlisib, cetuximab and irradiation in wild-type or PI3KCA-mutated head and neck cancer cell lines.
Lattanzio L; Tonissi F; Monteverde M; Vivenza D; Russi E; Milano G; Merlano M; Lo Nigro C
Invest New Drugs; 2015 Apr; 33(2):310-20. PubMed ID: 25603975
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
